全球肌红蛋白市场 – 行业趋势和 2031 年预测

肌红蛋白市场分析和规模

资金支持的激增可以归因于人们越来越认识到肌红蛋白在各个领域的关键作用，其中医疗保健是肌红蛋白市场的重要推动力。肌红蛋白检测市场的特点是存在成熟的诊断公司，包括雅培实验室、罗氏诊断、西门子医疗和 Ortho Clinical Diagnostics。

Data Bridge Market Research 分析，全球肌红蛋白市场规模在 2023 年为 9790 万美元，预计到 2031 年将达到 1.3502 亿美元，预计在 2024-2031 年预测期内的复合年增长率为 4.1%。由于“人类肌红蛋白细分市场”在医学研究和临床应用中变得重要，因此在肌红蛋白市场类型细分市场中占据主导地位。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

报告范围和市场细分

市场定义

肌红蛋白是一种存在于肌肉细胞中的蛋白质，负责结合和储存氧气。它在骨骼肌和心肌组织中含量特别丰富。从结构上讲，肌红蛋白类似于红细胞中的血红蛋白，但它对氧气的亲和力更高，因此它能够在肌肉活动期间储存氧气，而此时氧气供应可能有限。肌红蛋白的红色使肉类呈现出其特有的红褐色。

全球肌红蛋白市场动态

驱动程序

• 人口增长与城市化

As the global population grows, especially in urban areas where access to meat products is more prevalent, the demand for myoglobin-containing meats may increase. Population growth, especially in urban areas, typically leads to increased healthcare access, as cities tend to have more healthcare facilities, diagnostic centers, and medical professionals per capita. This increased access to healthcare services may result in higher demand for diagnostic tests, including myoglobin testing, as more people seek medical attention for acute conditions such as chest pain or sports injuries.

• Health Conditions Creates Demand for Diagnostic Tools

Diseases or conditions affecting muscle health or oxygen transport, such as anemia or certain cardiovascular disorders, may create demand for diagnostic tools or therapeutic interventions involving myoglobin. Elevated levels of myoglobin in the bloodstream are indicative of myocardial damage, making myoglobin testing crucial for diagnosing acute myocardial infarction (AMI), commonly known as a heart attack.

The prevalence of cardiovascular diseases, including heart attacks, coronary artery disease, and congestive heart failure, drives the demand for myoglobin testing as a diagnostic tool, especially in emergency and critical care settings.

Opportunities

• Technological Innovations Lead to Improvements in Myoglobin Production Efficiency

Advances in biotechnology, including genetic engineering and bioprocessing techniques, may lead to improvements in myoglobin production efficiency or the development of novel myoglobin based products.

• Market Expansion Growing Demand for Myoglobin-Containing Meat Products

With rising incomes and changing dietary preferences in emerging economies, there is potential for market expansion in regions where meat consumption is increasing. Companies could explore partnerships and distribution channels to capitalize on growing demand for myoglobin-containing meat products in these markets.

Restraints/Challenges

• Regulatory Challenges

Regulations governing the use of myoglobin in food products, including safety assessments and labeling requirements, can vary between countries and regions. Compliance with these regulations can be complex and may pose barriers to market entry or expansion.

• Cost of Production Challenges Industry Stakeholders

The production of myoglobin, whether through traditional meat processing or biotechnological methods, can involve significant costs related to research, development, and manufacturing. Achieving cost-effective production methods while maintaining product quality and safety standards is a challenge for industry stakeholders.

This global myoglobin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global myoglobin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In December 2022, Ergo Bioscience, a startup from Argentina, announced the development of plant-based versions of animal ingredients using precision fermentation. This includes myoglobin and casein
• In November 2022, Ergo Bioscience partnered with Aethera Biotech to scale up its precision fermentation bioprocesses. The partnership will focus on improving the biotech processes for producing animal-free myoglobin and casein

Global Myoglobin Market Scope

The global myoglobin market is segmented on the basis of product, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product

• Human Myoglobin
• Animal Myoglobin

End User

• Hospitals
• Diagnostic Laboratories
• Others

Global Myoglobin Market Regional Analysis/Insights

The global myoglobin market is analyzed and market size insights and trends are provided by product, and end user as referenced above.

The countries covered in the global myoglobin market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, and rest of Middle East and Africa.

North America dominates the myoglobin market due to the rising awareness of cardiovascular health.

Asia-Pacific is expected to show a rapid and lucrative growth rate due to favorable government initiatives.

肌红蛋白市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的竞争激烈或稀缺而面临的挑战、国内关税和贸易路线的影响。对肌红蛋白市场进行了分析，并按国家、产品、最终用户提供了市场规模洞察和趋势，如上所述。

竞争格局和全球肌红蛋白市场份额分析

全球肌红蛋白市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球肌红蛋白市场的关注有关。

全球肌红蛋白市场的一些主要参与者包括：

• Bio-Rad Laboratories Inc.（美国）
• 默克集团（德国）
• OriGene Technologies, Inc.（美国）
• 斯克里普斯实验室（美国）
• ThermoFisher Scientific, Inc.（美国）

SKU-70684